Global Plasma Fractionation Market – Industry Analysis and Forecast (2017-2024) _ by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Plasma Products), by Application, by End-User and by Geography

Global Plasma Fractionation Market – Industry Analysis and Forecast (2017-2024) _ by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Plasma Products), by Application, by End-User and by Geography

Market Scenario

Global Plasma Fractionation Market is expected to reach USD 41.95 Billion by 2024 from USD 24.75 Billion in 2016 at CAGR of 6.82% (Detailed analysis of the market CAGR is provided in the report). Global Plasma Fractiontion Market Plasma Fractionation is basically processing where various components of plasma are separated through blood fractionation and then Fresh Frozen Plasma (FFP) can be used for replacement of clotting factors. Plasma Fractionation is useful in the prevention and treatment of life-threatening diseases caused by trauma, immunologic disorders, and infections. Global Plasma Fractionation Market is segmented by product, application, end user, and geography. Product segment is sub-segmented as immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products. Application segment is divided as neurology, immunology, hematology, critical care, and others. An end-user segment is classified as hospitals & clinics, clinical research laboratories, and academic institutes. Hospital and clinic end-user segment is expected to lead the market growth during the forecast period. This growth is attributed to increasing number of hospitals & clinics across the globe and increasing adoption of plasma products in the treatment of various diseases. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing geriatric population across the globe and rising prevalence of respiratory diseases are trending the overall Global Plasma Fractionation Market. However, high cost and limited reimbursement will restrain market growth. North America is expected to dominate the Plasma Fractionation Market in forecast period followed by Europe and APAC. Technologically advanced research and increased use of immunoglobulins in neurological diseases and prophylaxis treatments for diagnosed patients in this region will fuel the Plasma Fractionation Market in the North America region. Key Highlights: • Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Plasma Fractionation Market analysis and comprehensive segmentation with respect to the product, application, end user, and geography to assist in strategic business planning • Global Plasma Fractionation Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions Research Methodology: The research methodology used in this report contains various secondary sources including Bloomberg, Hoovers, and Factiva. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Plasma Fractionation Market globally. Key Players in the Global Plasma Fractionation Market Are: • Green Cross Corporation • Baxalta Incorporated • Shanghai Raas Blood Products • Japan Blood Products Organization • Bio Products Laboratory (BPL) • China Biologic Products • Sanquin • Biotest • LFB • Kedrion • Octapharma • Shire • Grifols • CSL Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Healthcare Institutions (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Pharmacies, Ambulatory Centers, and Outpatient Clinics) • Health insurance provider companies • Research and development (R&D) companies • Pharmaceutical and biotechnological companies • Plasma fractionation products manufacturers and distributors • Healthcare service providers (including hospitals and clinics) • Contract research organizations (CROs) • Government Bodies The scope of the Report: Research report categorizes the Global Plasma Fractionation Market based on product, application, end user, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Plasma Fractionation Market with key developments in companies and market trends. Global Plasma Fractionation Market, By Product: • Immunoglobulin • Intravenous Immunoglobulin (IVIG) • Subcutaneous Immunoglobulin (SCIG) • Other Immunoglobulins • Coagulation Factor Concentrates • Factor VIII • Factor IX • Von Willebrand Factor • Prothrombin Complex Concentrate • Fibrinogen Concentrates • Factor XIII • Albumin • Protease Inhibitors • Other Plasma Products Global Plasma Fractionation Market, By Application: • Neurology • Immunology • Hematology • Critical Care • Pulmonology • Hemato-Oncology • Rheumatology • Other Applications Global Plasma Fractionation Market, By End-User: • Hospitals & Clinics • Clinical Research Laboratories • Academic Institutes Global Plasma Fractionation Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.   Global Practice Management System Market : Global industry Analysis and Forecast 2024

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT (2017-2024) 5.1. Introduction 5.2. Immunoglobulin 5.2.1. Immunoglobulin Market Overview 5.2.2. Immunoglobulin Market Size & Forecast 5.2.2.1. Intravenous Immunoglobulin (IVIG) 5.2.2.2. Subcutaneous Immunoglobulin (SCIG) 5.2.2.3. Other Immunoglobulins 5.3. Coagulation Factor Concentrates 5.3.1. Coagulation Factor Concentrates Market Overview 5.3.2. Coagulation Factor Concentrates Market Size & Forecast 5.3.2.1. Factor VIII 5.3.2.2. Factor IX 5.3.2.3. Von Willebrand Factor 5.3.2.4. Prothrombin Complex Concentrate 5.3.2.5. Fibrinogen Concentrates 5.3.2.6. Factor XIII 5.4. Albumin 5.4.1. Albumin Market Overview 5.4.2. Albumin Market Size & Forecast 5.5. Protease Inhibitors 5.5.1. Protease Inhibitors Market Overview 5.5.2. Protease Inhibitors Market Size & Forecast 5.6. Other Plasma Products 5.6.1. Other Plasma Products Market Overview 5.6.2. Other Plasma Products Market Size & Forecast 6. GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION (2017-2024) 6.1. Introduction 6.2. Neurology 6.2.1. Neurology Market Overview 6.2.2. Neurology Market Size & Forecast 6.3. Immunology 6.3.1. Immunology Market Overview 6.3.2. Immunology Market Size & Forecast 6.4. Hematology 6.4.1. Hematology Market Overview 6.4.2. Hematology Market Size & Forecast 6.5. Critical Care 6.5.1. Critical Care Market Overview 6.5.2. Critical Care Market Size & Forecast 6.6. Pulmonology 6.6.1. Pulmonology Market Overview 6.6.2. Pulmonology Market Size & Forecast 6.7. Hemato-Oncology 6.7.1. Hemato-Oncology Market Overview 6.7.2. Hemato-Oncology Market Size & Forecast 6.8. Rheumatology 6.8.1. Rheumatology Market Overview 6.8.2. Rheumatology Market Size & Forecast 6.9. Other Applications 6.9.1. Other Applications Market Overview 6.9.2. Other Applications Market Size & Forecast 7. GLOBAL PLASMA FRACTIONATION MARKET, BY END-USER (2017-2024) 7.1. Introduction 7.2. Hospitals & Clinics 7.2.1. Hospitals & Clinics Market Overview 7.2.2. Hospitals & Clinics Market Size & Forecast 7.3. Clinical Research Laboratories 7.3.1. Clinical Research Laboratories Market Overview 7.3.2. Clinical Research Laboratories Market Size & Forecast 7.4. Academic Institutes 7.4.1. Academic Institutes Market Overview 7.4.2. Academic Institutes Market Size & Forecast 8. GLOBAL PLASMA FRACTIONATION MARKET, BY GEOGRAPHY (2017-2024) 8.1. North America Plasma Fractionation Market 8.1.1. North America Plasma Fractionation Market, By Product 8.1.2. North America Plasma Fractionation Market, By Application 8.1.3. North America Plasma Fractionation Market, By End-User 8.1.4. North America Plasma Fractionation Market, by Region 8.1.4.1. U.S. Plasma Fractionation Market 8.1.4.2. Canada Plasma Fractionation Market 8.1.4.3. Mexico Plasma Fractionation Market 8.2. Europe Plasma Fractionation Market 8.2.1. Europe Plasma Fractionation Market, By Product 8.2.2. Europe Plasma Fractionation Market, By Application 8.2.3. Europe Plasma Fractionation Market, By End-User 8.2.4. Europe Global Plasma Fractionation Market, by Region 8.2.4.1. France Plasma Fractionation Market 8.2.4.2. Germany Plasma Fractionation Market 8.2.4.3. U.K. Plasma Fractionation Market 8.2.4.4. Italy Plasma Fractionation Market 8.2.4.5. Spain Plasma Fractionation Market 8.2.4.6. Rest of Europe Plasma Fractionation Market 8.3. Asia Pacific Plasma Fractionation Market 8.3.1. Asia-Pacific Plasma Fractionation Market, By Product 8.3.2. Asia-Pacific Plasma Fractionation Market, By Application 8.3.3. Asia-Pacific Plasma Fractionation Market, By End-User 8.3.4. Asia-Pacific Plasma Fractionation Market, by Region 8.3.4.1. China Plasma Fractionation Market 8.3.4.2. Japan Plasma Fractionation Market 8.3.4.3. India Plasma Fractionation Market 8.3.4.4. South Korea Plasma Fractionation Market 8.3.4.5. Rest of Asia Pacific Plasma Fractionation Market 8.4. Middle East & Africa Plasma Fractionation Market 8.4.1. Middle East & Africa Plasma Fractionation Market, By Product 8.4.2. Middle East & Africa Plasma Fractionation Market, By Application 8.4.3. Middle East & Africa Plasma Fractionation Market, By End-User 8.4.4. Middle East & Africa Plasma Fractionation Market, by Region 8.4.4.1. South Africa Plasma Fractionation Market 8.4.4.2. Rest of Middle East and Africa Plasma Fractionation Market 8.5. Latin America Plasma Fractionation Market 8.5.1. Latin America Plasma Fractionation Market, By Product 8.5.2. Latin America Plasma Fractionation Market, By Application 8.5.3. Latin America Plasma Fractionation Market, By End-User 8.5.4. Latin America Plasma Fractionation Market, by Region 8.5.4.1. Brazil Plasma Fractionation Market 8.5.4.2. Rest of Latin America Plasma Fractionation Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Green Cross Corporation 9.3.1.1 Overview 9.3.1.2 Products/ End-User 9.3.1.3 Strategy 9.3.1.4 Key Developments 9.3.2 Baxalta Incorporated 9.3.2.1 Overview 9.3.2.2 Products/ End-User 9.3.2.3 Strategy 9.3.2.4 Key Developments 9.3.3 Shanghai Raas Blood Products 9.3.3.1 Overview 9.3.3.2 Products/ End-User 9.3.3.3 Strategy 9.3.3.4 Key Developments 9.3.4 Japan Blood Products Organization 9.3.4.1 Overview 9.3.4.2 Products/ End-User 9.3.4.3 Strategy 9.3.4.4 Key Developments 9.3.5 Bio Products Laboratory (BPL) 9.3.5.1 Overview 9.3.5.2 Products/ End-User 9.3.5.3 Strategy 9.3.5.4 Key Developments 9.3.6 China Biologic Products 9.3.6.1 Overview 9.3.6.2 Products/ End-User 9.3.6.3 Strategy 9.3.6.4 Key Developments 9.3.7 Sanquin 9.3.7.1 Overview 9.3.7.2 Products/ End-User 9.3.7.3 Strategy 9.3.7.4 Key Development 9.3.8 Biotest 9.3.8.1 Overview 9.3.8.2 Products/ End-User 9.3.8.3 Strategy 9.3.8.4 Key Development 9.3.9 LFB 9.3.9.1 Overview 9.3.9.2 Products/ End-User 9.3.9.3 Strategy 9.3.9.4 Key Development 9.3.10 Kedrion 9.3.10.1 Overview 9.3.10.2 Products/ End-User 9.3.10.3 Strategy 9.3.10.4 Key Development 9.3.11 Octapharma 9.3.11.1 Overview 9.3.11.2 Products/ End-User 9.3.11.3 Strategy 9.3.11.4 Key Development 9.3.12 Shire 9.3.12.1 Overview 9.3.12.2 Products/ End-User 9.3.12.3 Strategy 9.3.12.4 Key Development 9.3.13 Grifols 9.3.13.1 Overview 9.3.13.2 Products/ End-User 9.3.13.3 Strategy 9.3.13.4 Key Development 9.3.14 CSL 9.3.14.1 Overview 9.3.14.2 Products/ End-User 9.3.14.3 Strategy 9.3.14.4 Key Development

Inquiry Before Buying

Request Sample

About This Report

Report ID6677
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now